#allposts — Public Fediverse posts

Canadian Letter: VPH stock has an upside of 344%, Echelon says https://www.cantechletter.com/2023/11/vph-stock-has-an-upside-of-344-echelon-says/ #canada #tech #Technology #LifeSciences #Allposts #Analysts #vph

Canadian Letter: VPH stock has an upside of 344%, Echelon says https://www.cantechletter.com/2023/11/vph-stock-has-an-upside-of-344-echelon-says/ #canada #tech #Technology #LifeSciences #Allposts #Analysts #vph

Canadian Letter: VPH stock has an upside of 344%, Echelon says https://www.cantechletter.com/2023/11/vph-stock-has-an-upside-of-344-echelon-says/ #canada #tech #Technology #LifeSciences #Allposts #Analysts #vph

Canadian Letter: VPH stock has an upside of 344%, Echelon says https://www.cantechletter.com/2023/11/vph-stock-has-an-upside-of-344-echelon-says/ #canada #tech #Technology #LifeSciences #Allposts #Analysts #vph

Canadian Letter: WNDR stock is an interesting crypto play, Haywood says https://www.cantechletter.com/2023/10/wndr-stock-is-an-interesting-crypto-play-haywood-says/ #canada #tech #Technology #Allposts #Analysts #Crypto #wndr

Canadian Letter: WNDR stock is an interesting crypto play, Haywood says https://www.cantechletter.com/2023/10/wndr-stock-is-an-interesting-crypto-play-haywood-says/ #canada #tech #Technology #Allposts #Analysts #Crypto #wndr

Canadian Letter: WNDR stock is an interesting crypto play, Haywood says https://www.cantechletter.com/2023/10/wndr-stock-is-an-interesting-crypto-play-haywood-says/ #canada #tech #Technology #Allposts #Analysts #Crypto #wndr

Canadian Letter: WNDR stock is an interesting crypto play, Haywood says https://www.cantechletter.com/2023/10/wndr-stock-is-an-interesting-crypto-play-haywood-says/ #canada #tech #Technology #Allposts #Analysts #Crypto #wndr

Canadian Letter: Neighbourly Pharmacy stock soars on go-private deal https://www.cantechletter.com/2023/10/neighbourly-pharmacy-stock-soars-on-go-private-deal/ #canada #tech #Technology #Allposts #nbly

Canadian Letter: Neighbourly Pharmacy stock soars on go-private deal https://www.cantechletter.com/2023/10/neighbourly-pharmacy-stock-soars-on-go-private-deal/ #canada #tech #Technology #Allposts #nbly

Canadian Letter: Neighbourly Pharmacy stock soars on go-private deal https://www.cantechletter.com/2023/10/neighbourly-pharmacy-stock-soars-on-go-private-deal/ #canada #tech #Technology #Allposts #nbly

Canadian Letter: Neighbourly Pharmacy stock soars on go-private deal https://www.cantechletter.com/2023/10/neighbourly-pharmacy-stock-soars-on-go-private-deal/ #canada #tech #Technology #Allposts #nbly

Canadian Letter: Alithya Group: IA Capital launches coverage with “Buy” rating https://www.cantechletter.com/2023/09/alithya-group-ia-capital-launches-coverage-with-buy-rating/ #canada #tech #Technology #Allposts #Analysts #alya #IT

Canadian Letter: Valeo Pharma is a 6x return, says Paradigm https://www.cantechletter.com/2023/06/valeo-pharma-is-a-6x-return-says-paradigm/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #vph

Canadian Letter: Valeo Pharma is a 6x return, says Paradigm https://www.cantechletter.com/2023/06/valeo-pharma-is-a-6x-return-says-paradigm/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #vph

Canadian Letter: Valeo Pharma is a 6x return, says Paradigm https://www.cantechletter.com/2023/06/valeo-pharma-is-a-6x-return-says-paradigm/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #vph

Canadian Letter: Valeo Pharma is a 6x return, says Paradigm https://www.cantechletter.com/2023/06/valeo-pharma-is-a-6x-return-says-paradigm/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #vph

Canadian Letter: Valeo Pharma has a 178 per cent upside, says Echelon https://www.cantechletter.com/2023/06/valeo-pharma-has-a-178-per-cent-upside-says-echelon/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #vph

Canadian Letter: Valeo Pharma has a 178 per cent upside, says Echelon https://www.cantechletter.com/2023/06/valeo-pharma-has-a-178-per-cent-upside-says-echelon/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #vph

Canadian Letter: Valeo Pharma has a 178 per cent upside, says Echelon https://www.cantechletter.com/2023/06/valeo-pharma-has-a-178-per-cent-upside-says-echelon/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #vph

Canadian Letter: Valeo Pharma has a 178 per cent upside, says Echelon https://www.cantechletter.com/2023/06/valeo-pharma-has-a-178-per-cent-upside-says-echelon/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #vph

Canadian Letter: Beat the market with Valeo Pharma, says Research Capital https://www.cantechletter.com/2023/06/beat-the-market-with-valeo-pharma-says-research-capital/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #vph

Canadian Letter: Beat the market with Valeo Pharma, says Research Capital https://www.cantechletter.com/2023/06/beat-the-market-with-valeo-pharma-says-research-capital/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #vph

Canadian Letter: Beat the market with Valeo Pharma, says Research Capital https://www.cantechletter.com/2023/06/beat-the-market-with-valeo-pharma-says-research-capital/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #vph

Canadian Letter: Beat the market with Valeo Pharma, says Research Capital https://www.cantechletter.com/2023/06/beat-the-market-with-valeo-pharma-says-research-capital/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #vph

Canadian Letter: Peloton has target cut by Roth Capital https://www.cantechletter.com/2023/05/peloton-has-target-cut-by-roth-capital/ #canada #tech #Technology #Allposts #Analysts #pton

Canadian Letter: Peloton has target cut by Roth Capital https://www.cantechletter.com/2023/05/peloton-has-target-cut-by-roth-capital/ #canada #tech #Technology #Allposts #Analysts #pton

Canadian Letter: Peloton has target cut by Roth Capital https://www.cantechletter.com/2023/05/peloton-has-target-cut-by-roth-capital/ #canada #tech #Technology #Allposts #Analysts #pton

Canadian Letter: Peloton has target cut by Roth Capital https://www.cantechletter.com/2023/05/peloton-has-target-cut-by-roth-capital/ #canada #tech #Technology #Allposts #Analysts #pton

Canadian Letter: Huge upside to Journey Medical, says Roth https://www.cantechletter.com/2023/03/huge-upside-to-journey-medical-says-roth/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #derm

Canadian Letter: Huge upside to Journey Medical, says Roth https://www.cantechletter.com/2023/03/huge-upside-to-journey-medical-says-roth/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #derm

Canadian Letter: Huge upside to Journey Medical, says Roth https://www.cantechletter.com/2023/03/huge-upside-to-journey-medical-says-roth/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #derm

Canadian Letter: Huge upside to Journey Medical, says Roth https://www.cantechletter.com/2023/03/huge-upside-to-journey-medical-says-roth/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #derm

Canadian Letter: Healthcare stocks are looking attractive, says iA Capital https://www.cantechletter.com/2023/02/healthcare-stocks-are-looking-attractive-says-ia-capital/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #Health #acog #arch #care #crbk #crrx #nbly #ngen #qipt #dht #hls #htl #imv #lxg #mbx #sva #vph #dr

Canadian Letter: Healthcare stocks are looking attractive, says iA Capital https://www.cantechletter.com/2023/02/healthcare-stocks-are-looking-attractive-says-ia-capital/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #Health #acog #arch #care #crbk #crrx #nbly #ngen #qipt #dht #hls #htl #imv #lxg #mbx #sva #vph #dr

Canadian Letter: Healthcare stocks are looking attractive, says iA Capital https://www.cantechletter.com/2023/02/healthcare-stocks-are-looking-attractive-says-ia-capital/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #Health #acog #arch #care #crbk #crrx #nbly #ngen #qipt #dht #hls #htl #imv #lxg #mbx #sva #vph #dr

Canadian Letter: Healthcare stocks are looking attractive, says iA Capital https://www.cantechletter.com/2023/02/healthcare-stocks-are-looking-attractive-says-ia-capital/ #canada #tech #Technology #PharmaandBiotech #Allposts #Analysts #Health #acog #arch #care #crbk #crrx #nbly #ngen #qipt #dht #hls #htl #imv #lxg #mbx #sva #vph #dr

Canadian Letter: iA Capital lowers target on Microbix Biosystems https://www.cantechletter.com/2022/12/ia-capital-lowers-target-on-microbix-biosystems/ #canada #tech #Technology #Allposts #Analysts #Health #mbx

Canadian Letter: iA Capital lowers target on Microbix Biosystems https://www.cantechletter.com/2022/12/ia-capital-lowers-target-on-microbix-biosystems/ #canada #tech #Technology #Allposts #Analysts #Health #mbx

Canadian Letter: iA Capital lowers target on Microbix Biosystems https://www.cantechletter.com/2022/12/ia-capital-lowers-target-on-microbix-biosystems/ #canada #tech #Technology #Allposts #Analysts #Health #mbx